|
Name |
Methyl tridecanoate
|
Molecular Formula | C14H28O2 | |
IUPAC Name* |
methyl tridecanoate
|
|
SMILES |
CCCCCCCCCCCCC(=O)OC
|
|
InChI |
InChI=1S/C14H28O2/c1-3-4-5-6-7-8-9-10-11-12-13-14(15)16-2/h3-13H2,1-2H3
|
|
InChIKey |
JNDDPBOKWCBQSM-UHFFFAOYSA-N
|
|
Synonyms |
METHYL TRIDECANOATE; 1731-88-0; Tridecanoic acid, methyl ester; Tridecanoic acid methyl ester; Methyl n-tridecanoate; 61788-59-8; MFCD00008977; O2H463RING; n-Tridecanoic acid methyl ester; NSC-163375; 67762-40-7; EINECS 217-054-8; UNII-O2H463RING; NSC 163375; BRN 1769695; Tridecanoic acid,methyl ester; methyl tridecylate; Tridecanoic acid methyl; Methyl tridecanoate ester; tridecanoic acid-methyl ester; 4-02-00-01118 (Beilstein Handbook Reference); QSPL 203; SCHEMBL1647268; DTXSID8061923; Methyl ester of tridecanoic acid; CDAA-251013M; CHEBI:143578; BAA73188; ZINC1635630; EINECS 267-018-0; Methyl tridecanoate, >=97% (GC); NSC163375; AKOS015839775; CS-W004287; HY-W004287; Methyl tridecanoate, analytical standard; AS-60387; SY051771; DB-043928; FT-0633801; T0960; H10828; A881801; J-010886; Q24764359; EF80D759-D71D-495A-A128-F98E5A2D6415; 6-OXO-9ALPHA,11ALPHA,15S-TRIHYDROXY-PROSTA-13E,17Z-DIEN-1-OICACID
|
|
CAS | 1731-88-0 | |
PubChem CID | 15608 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 228.37 | ALogp: | 6.3 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 12 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 16 | QED Weighted: | 0.368 |
Caco-2 Permeability: | -4.637 | MDCK Permeability: | 0.00001990 |
Pgp-inhibitor: | 0.27 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.986 |
30% Bioavailability (F30%): | 0.99 |
Blood-Brain-Barrier Penetration (BBB): | 0.882 | Plasma Protein Binding (PPB): | 96.57% |
Volume Distribution (VD): | 1.029 | Fu: | 2.42% |
CYP1A2-inhibitor: | 0.926 | CYP1A2-substrate: | 0.362 |
CYP2C19-inhibitor: | 0.616 | CYP2C19-substrate: | 0.252 |
CYP2C9-inhibitor: | 0.391 | CYP2C9-substrate: | 0.927 |
CYP2D6-inhibitor: | 0.061 | CYP2D6-substrate: | 0.091 |
CYP3A4-inhibitor: | 0.38 | CYP3A4-substrate: | 0.094 |
Clearance (CL): | 5.91 | Half-life (T1/2): | 0.483 |
hERG Blockers: | 0.138 | Human Hepatotoxicity (H-HT): | 0.028 |
Drug-inuced Liver Injury (DILI): | 0.262 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.031 | Maximum Recommended Daily Dose: | 0.02 |
Skin Sensitization: | 0.946 | Carcinogencity: | 0.095 |
Eye Corrosion: | 0.956 | Eye Irritation: | 0.975 |
Respiratory Toxicity: | 0.876 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000604 | 0.938 | D05ATI | 0.586 | ||||
ENC000260 | 0.933 | D07ILQ | 0.544 | ||||
ENC000560 | 0.882 | D0Z5SM | 0.523 | ||||
ENC000271 | 0.833 | D0O1PH | 0.480 | ||||
ENC000249 | 0.800 | D0XN8C | 0.425 | ||||
ENC000496 | 0.789 | D00FGR | 0.412 | ||||
ENC001519 | 0.759 | D00MLW | 0.402 | ||||
ENC000280 | 0.750 | D09ANG | 0.400 | ||||
ENC001377 | 0.741 | D00AOJ | 0.400 | ||||
ENC000642 | 0.731 | D0Z5BC | 0.397 |